Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young Seob Shin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Lung Cancer|August 21, 2025
What is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (≥ 5 cm) Non-Small Cell Lung Cancer?Ye Jin Yoo, Si Yeol Song, Young Seob Shin, et al.
Journal of Clinical Medicine|November 13, 2025
Local Control and Vertebral Compression Fractures After Stereotactic Body Radiotherapy for Spinal MetastasesHa Un Kim, Jinhong Jung, Young Seok Kim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2024
Predictive value of primary tumor volume change during concurrent chemoradiotherapy in patients with unresectable stage III non-small cell lung cancerHye In Lee, Eun Kyung Choi, Su Ssan Kim, et al.
Journal of Endodontics|March 4, 2015
Color changes of teeth after treatment with various mineral trioxide aggregate-based materials: an ex vivo studyShin-Hong Kang, Young-Seob Shin, Hyo-Seol Lee, et al.
Radiation Oncology Journal|October 4, 2023
Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancerEunyeong Yang, Young Seob Shin, Ji Hyeon Joo, et al.
Cancer Research and Treatment|March 24, 2023
Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution ExperienceJeong Yun Jang, Su Ssan Kim, Si Yeol Song, et al.
Thoracic Cancer|June 27, 2023
Efficacy of lazertinib for symptomatic or asymptomatic brain metastases in treatment-naive patients with advanced EGFR mutation-positive non-small cell lung cancer: Protocol of an open-label, single-arm phase II trialBora Lee, Wonjun Ji, Jae Cheol Lee, et al.
Journal of Medical Imaging and Radiation Oncology|September 9, 2024
Long-term outcomes and risk profile of cT3N0 breast cancer treated with neoadjuvant chemotherapy and curative surgeryYoung Seob Shin, Jae Ho Jeong, Il Yong Chung, et al.
Leukemia & Lymphoma|March 6, 2025
Deintensification of radiation dose to 20 Gy for conjunctival mucosa-associated lymphoid tissue (MALT) lymphomaJaeha Lee, Si Yeol Song, Young Seob Shin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2024
Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning AnalysisHye In Lee, Eun Kyung Choi, Su Ssan Kim, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Lung Cancer|August 21, 2025
What is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (≥ 5 cm) Non-Small Cell Lung Cancer?Ye Jin Yoo, Si Yeol Song, Young Seob Shin, et al.
Journal of Clinical Medicine|November 13, 2025
Local Control and Vertebral Compression Fractures After Stereotactic Body Radiotherapy for Spinal MetastasesHa Un Kim, Jinhong Jung, Young Seok Kim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2024
Predictive value of primary tumor volume change during concurrent chemoradiotherapy in patients with unresectable stage III non-small cell lung cancerHye In Lee, Eun Kyung Choi, Su Ssan Kim, et al.
Journal of Endodontics|March 4, 2015
Color changes of teeth after treatment with various mineral trioxide aggregate-based materials: an ex vivo studyShin-Hong Kang, Young-Seob Shin, Hyo-Seol Lee, et al.
Radiation Oncology Journal|October 4, 2023
Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancerEunyeong Yang, Young Seob Shin, Ji Hyeon Joo, et al.
Cancer Research and Treatment|March 24, 2023
Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution ExperienceJeong Yun Jang, Su Ssan Kim, Si Yeol Song, et al.
Thoracic Cancer|June 27, 2023
Efficacy of lazertinib for symptomatic or asymptomatic brain metastases in treatment-naive patients with advanced EGFR mutation-positive non-small cell lung cancer: Protocol of an open-label, single-arm phase II trialBora Lee, Wonjun Ji, Jae Cheol Lee, et al.
Journal of Medical Imaging and Radiation Oncology|September 9, 2024
Long-term outcomes and risk profile of cT3N0 breast cancer treated with neoadjuvant chemotherapy and curative surgeryYoung Seob Shin, Jae Ho Jeong, Il Yong Chung, et al.
Leukemia & Lymphoma|March 6, 2025
Deintensification of radiation dose to 20 Gy for conjunctival mucosa-associated lymphoid tissue (MALT) lymphomaJaeha Lee, Si Yeol Song, Young Seob Shin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2024
Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning AnalysisHye In Lee, Eun Kyung Choi, Su Ssan Kim, et al.
Pageof 2